StocksMedium•8 October 2026•
1 min read
Haemonetics Stock Rallies on Expanded CSL Plasma Supply Deal
Key Facts
1CSL Plasma plans to deploy Haemonetics' plasma collection equipment across all its existing U.S. centers.
Haemonetics Corporation shares surged following an update to its supply agreement with CSL Plasma to expand the use of its technology. Barron's reported that CSL Plasma plans to deploy Haemonetics' plasma collection equipment across all its existing U.S. centers.
HAE closed at $101.71 on October 7, 2026, after reaching a session high of $104.02. The expansion of the existing agreement opens the door to significant additional revenue by increasing the footprint of the company's equipment in the U.S. market.